Cognition Therapeutics Inc (CGTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -11,716 | -4,377 | -1,267 | 223 | -7,839 |
| Depreciation Amortization | 476 | 453 | 430 | 305 | 934 |
| Accounts receivable | -1,114 | -19 | -1,411 | -1,174 | N/A |
| Accounts payable and accrued liabilities | 2,165 | -278 | 420 | 953 | N/A |
| Other Working Capital | 2,842 | 604 | 571 | 108 | 3,067 |
| Other Operating Activity | 3,716 | -115 | -425 | -1,187 | 405 |
| Operating Cash Flow | $-3,631 | $-3,732 | $-1,682 | $-772 | $-3,433 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -27 | N/A | N/A | N/A | -10 |
| Investing Cash Flow | $-27 | $N/A | $N/A | $N/A | $-10 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 8,942 | 8,942 | 8,942 | 8,942 | N/A |
| Common Stock Issued | 44,527 | 53 | 48 | 14 | N/A |
| Other Financing Activity | -268 | -2,155 | -1,189 | 0 | 5,765 |
| Financing Cash Flow | $53,201 | $6,840 | $7,801 | $8,956 | $5,765 |
| Exchange Rate Effect | -11 | 13 | -8 | N/A | -23 |
| Beginning Cash Position | 5,189 | 5,189 | 5,189 | 5,189 | 2,890 |
| End Cash Position | 54,721 | 8,310 | 11,300 | 13,373 | 5,189 |
| Net Cash Flow | $49,532 | $3,121 | $6,111 | $8,184 | $2,299 |
| Free Cash Flow | |||||
| Operating Cash Flow | -3,631 | -3,732 | -1,682 | -772 | -3,433 |
| Capital Expenditure | -27 | N/A | N/A | N/A | N/A |
| Free Cash Flow | -3,658 | -3,732 | -1,682 | -772 | -3,433 |